-Reduction in risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy” (“ LIFE indication” )” During the referral procedure, the MAH proposed amending the indication to substitute “ cardiovascular morbidity and mortality” with “ stroke”.